SUMMARY
- Continued geopolitical and economic headwinds, particularly for the quality growth holdings targeted by the strategy.
- New positions added to benefit from de-globalisation and industrial onshoring.
- Notwithstanding compelling company fundamentals, Chinese exposure was reduced due to increased country risk concerns.
Markets have been buffeted by stubbornly high inflation, aggressive interest rate hikes, the ongoing war between Russia and Ukraine, and COVID-19 lockdowns in China. The MSCI ACWI Index declined by 8%, the worst monthly performance since the onset of the COVID-19 pandemic in March 2020. Growth stocks led the way down, continuing their year-to-date underperformance — the MSCI ACWI Growth Index has declined nearly 20% in 2022. Declines were broad across sectors and regions. The US performed the worst due to the sharp decline in technology stocks; the NASDAQ Index had its worst month since October 2008.
The Portfolio fell -6.5% in April, compared to the Index (MSCI World Total Return Index, Net Dividend Reinvested, in A$) which fell -3.1% for the same period.